Iqvia Holdings (IQV) Income from Continuing Operations (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Income from Continuing Operations came in at 269000000.0 in Q1 2026, up 2.67% year-on-year from 262000000.0 in Q1 2025, and down 43.72% quarter-over-quarter from 478000000.0 in Q4 2025.
Iqvia Holdings (IQV) Income from Continuing Operations (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Income from Continuing Operations across 15 years of filings, most recently posting 269000000.0 for Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 269000000.0, up 2.67% year-over-year; the trailing twelve-month figure through Mar 2026 was 1346000000.0 (up 0.52% YoY), and the FY2025 annual result was 1339000000.0, down 2.12% from the prior year.
- Income from Continuing Operations came in at 269000000.0 for Q1 2026 at Iqvia Holdings, down from 478000000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 478000000.0 in Q4 2025 to a low of 227000000.0 in Q4 2022.
- The 5-year median for Income from Continuing Operations is 291000000.0 (2023), against an average of 319823529.41.
- Across the five-year window, Income from Continuing Operations decreased 28.39% in 2022 and jumped 109.25% in 2023, its largest moves.
- Iqvia Holdings' Income from Continuing Operations stood at 227000000.0 in 2022, then surged by 109.25% to 475000000.0 in 2023, then retreated by 9.05% to 432000000.0 in 2024, then climbed by 10.65% to 478000000.0 in 2025, then slumped by 43.72% to 269000000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 269000000.0 (Q1 2026), 478000000.0 (Q4 2025), and 332000000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | 260.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 269.00 Mn |
| Dec 31, 2025 | 478.00 Mn |
| Sep 30, 2025 | 332.00 Mn |
| Jun 30, 2025 | 267.00 Mn |
| Mar 31, 2025 | 262.00 Mn |
| Dec 31, 2024 | 432.00 Mn |
| Sep 30, 2024 | 284.00 Mn |
| Jun 30, 2024 | 361.00 Mn |
| Mar 31, 2024 | 291.00 Mn |
| Dec 31, 2023 | 475.00 Mn |
| Sep 30, 2023 | 298.00 Mn |
| Jun 30, 2023 | 294.00 Mn |
| Mar 31, 2023 | 291.00 Mn |
| Dec 31, 2022 | 227.00 Mn |
| Sep 30, 2022 | 290.00 Mn |
| Jun 30, 2022 | 257.00 Mn |
| Mar 31, 2022 | 329.00 Mn |
| Dec 31, 2021 | 317.00 Mn |
| Sep 30, 2021 | 261.00 Mn |
| Jun 30, 2021 | 174.00 Mn |